1. Home
  2. TMDX vs APGE Comparison

TMDX vs APGE Comparison

Compare TMDX & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$99.21

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$77.78

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
APGE
Founded
1998
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.7B
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
TMDX
APGE
Price
$99.21
$77.78
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$154.00
$109.25
AVG Volume (30 Days)
923.9K
1.0M
Earning Date
05-07-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
382.18
N/A
EPS
4.87
N/A
Revenue
$605,494,000.00
N/A
Revenue This Year
$24.51
N/A
Revenue Next Year
$18.73
N/A
P/E Ratio
$20.97
N/A
Revenue Growth
37.13
N/A
52 Week Low
$62.42
$26.20
52 Week High
$156.00
$85.04

Technical Indicators

Market Signals
Indicator
TMDX
APGE
Relative Strength Index (RSI) 24.72 60.14
Support Level N/A $73.06
Resistance Level $131.86 $81.04
Average True Range (ATR) 5.48 4.62
MACD -2.58 0.96
Stochastic Oscillator 3.82 73.26

Price Performance

Historical Comparison
TMDX
APGE

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: